首站-论文投稿智能助手
典型文献
A positive feedback loop of ARF6 activates ERK1/2 signaling pathway via DUSP6 silencing to promote pancreatic cancer progression
文献摘要:
ERK1/2 are essential proteins mediating mitogen-activated protein kinase signaling downstream of RAS in pancreatic adenocarcinoma(PDAC).Our previous study reveals that ARF6 plays a positive regulatory role in ERK1/2 pathway in a feedback loop manner.A significant part of the literature on ARF6 has emphasized its oncogenic effect as an essential downstream molecule of ERK1/2,and no research has been done on the regulation mechanisms of the feedback loop between ARF6 and the ERK1/2 signaling pathway.In the present study,we explore the gene network downstream of ARF6 and find that DUSP6 may be the critical signal molecule in the positive feedback loop between ARF6 and ERK1/2.Specifically,to elucidate the negative correlations between ARF6 and DUSP6 in pancreatic cancer,we examine their expressions in pancreatic cancer tissues by immunohistochemical staining.Then the impact of DUSP6 on the pro-liferation and apoptosis of PDAC cells are investigated by gain-of-function and loss-of-function approaches.Me-chanism explorations uncover that ARF6 suppresses the expression of DUSP6,which is responsible for the dephosphorylation of ERK1/2.Altogether,these results indicate that DUSP6 plays a tumor-suppressive role and acts as an intermediate molecule between ARF6 and ERK1/2 in PDAC cells,thereby forming a positive feedback loop.
文献关键词:
作者姓名:
Bingkai Xiao;Yue Zhang;Zekun Lu;Weibo Chen;Yong An;Guangchen Zu;Xiaowu Xu;Di Wu;Hao Yang;Yi Qin;Xuemin Chen
作者机构:
Department of Hepatopancreatobiliary Surgery,the Third Affiliated Hospital of Soochow University,Changzhou 213000,China;Department of Pancreatic Surgery,Fudan University Shanghai Cancer Center,Shanghai 200032,China
引用格式:
[1]Bingkai Xiao;Yue Zhang;Zekun Lu;Weibo Chen;Yong An;Guangchen Zu;Xiaowu Xu;Di Wu;Hao Yang;Yi Qin;Xuemin Chen-.A positive feedback loop of ARF6 activates ERK1/2 signaling pathway via DUSP6 silencing to promote pancreatic cancer progression)[J].生物化学与生物物理学报(英文版),2022(10):1431-1440
A类:
DUSP6,chanism
B类:
positive,feedback,loop,ARF6,activates,ERK1,signaling,pathway,via,silencing,promote,pancreatic,cancer,progression,are,essential,proteins,mediating,mitogen,activated,kinase,downstream,RAS,adenocarcinoma,PDAC,Our,previous,study,reveals,that,plays,regulatory,role,manner,significant,part,literature,emphasized,its,oncogenic,effect,molecule,research,been,done,regulation,mechanisms,between,In,present,explore,gene,network,find,may,critical,Specifically,elucidate,negative,correlations,examine,their,expressions,tissues,immunohistochemical,staining,Then,impact,liferation,apoptosis,cells,investigated,gain,function,loss,approaches,Me,explorations,uncover,suppresses,which,responsible,dephosphorylation,Altogether,these,results,indicate,tumor,suppressive,acts,intermediate,thereby,forming
AB值:
0.472907
相似文献
Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
Duo Zuo;Yongzi Chen;Xinwei Zhang;Zhuozhi Wang;Wenna Jiang;Fan Tang;Runfen Cheng;Yi Sun;Lu Sun;Li Ren;Rui Liu-Department of Clinical Laboratory;Department of Tumor Cell Biology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Biomedical Engineering,Tianjin Medical University,Tianjin 300070,China;Department of Pathology,Tianjin Huanhu Hospital,Tianjin 300350,China;Department of Pathology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,Tianjin Medical University,Tianjin 300070,China;Department of Gastrointestinal Medical Oncology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription
Xiaoqing Lu;Liwei An;Guangjian FanTi;Lijuan Zang;Weiyi Huang;Junjian Li;Jun Liu;Weiyu Ge;Yuwei Huang;Jingxuan Xu;Shaoqian Du;Yuan Cao;Tianhao Zhou;Huijing Yin;Li Yu;Shi Jiao;Hongxia Wang-State Key Laboratory of Oncogenes and Related Genes,Department of Oncology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Breast Surgery,Shanxi Cancer Hospital,Chinese Academy of Medical Sciences,Taiyuan,Shanxi,China;Department of Medical Ultrasound,Shanghai Tenth People's Hospital,Tongji University Cancer Center,School of Medicine,Tongji University,Shanghai,China;Precision Research Center for Refractory Diseases,Institute for Clinical Research,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Pathology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;State Key Laboratory of Membrane Biology,Tsinghua-Peking University Joint Center for Life Sciences,School of Life Science,Tsinghua University,Beijing,China;State Key Laboratory of Genetic Engineering,School of Life Sciences,Fudan University,Shanghai,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB/IL-6/STAT3 and JNK/PTX3 pathways
Wan Li;Hongqing Cai;Liwen Ren;Yihui Yang;Hong Yang;Jinyi Liu;Sha Li;Yizhi Zhang;Xiangjin Zheng;Wei Tan;Guanhua Du;Jinhua Wang-The State Key Laboratory of Bioactive Substance and Function of Natural Medicines,Beijing 100050,China;Key Laboratory of Drug Target Research and Drug Screen,Institute of Materia Medica,Chinese Academy of Medical Science and Peking Union Medical College,Beijing 100050,China;Department of Neurosurgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;State Key Laboratory of Molecular Oncology,Center for Cancer Precision Medicine,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;School of Pharmacy,Xinjiang Medical University,Urumqi 830011,China;Xinjiang Institute of Materia Medica,Urumqi 830004,China
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
Critical role of PAFR/YAP1 positive feedback loop in cardiac fibrosis
Tian-yu Li;Wei Su;Liang-liang Li;Xiao-guang Zhao;Na Yang;Jia-xin Gai;Xin Lv;Jing Zhang;Meng-qin Huang;Qing Zhang;Wei-hang Ji;Xiao-ying Song;Yu-hong Zhou;Xue-lian Li;Hong-li Shan;Hai-hai Liang-Department of Pharmacology(State-Province Key Laboratories of Biomedicine-Pharmaceutics of China,Key Laboratory of Cardiovascular Research,Ministry of Education),College of Pharmacy,Harbin Medical University,Harbin 150081,China;Zhuhai People's Hospital,Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment,Zhuhai Hospital Affiliated with Jinan University,Jinan University,Zhuhai 519000,China;Department of Cardiology,The Fourth Affiliated Hospital of Harbin Medical University,Harbin 150001,China;Shanghai Frontiers Science Research Center for Druggability of Cardiovascular Noncoding RNA,Institute for Frontier Medical Technology,Shanghai University of Engineering Science,Shanghai 201620,China;Research Unit of Noninfectious Chronic Diseases in Frigid Zone(2019RU070),Chinese Academy of Medical Sciences,Harbin 150081,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。